-
Notifications
You must be signed in to change notification settings - Fork 1
Commit
This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository.
- Loading branch information
1 parent
ba1fbc9
commit f4b6908
Showing
1 changed file
with
262 additions
and
0 deletions.
There are no files selected for viewing
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -1,2 +1,264 @@ | ||
# Protocols | ||
|
||
### 1. **Processing of RNA-Seq Data** | ||
**Materials**: | ||
- Computer with installed R studio and relevant bioinformatics packages. | ||
- Human tissue RNA-seq data from specified databases. | ||
|
||
**Procedure**: | ||
1. **Preparation**: Install necessary packages and libraries on R studio. Ensure stable internet connectivity for data download. | ||
2. **Data Download**: | ||
- Navigate to the respective database web pages. | ||
- Select the desired datasets and initiate download. | ||
- Store data in a specified folder for easy access. | ||
3. **Processing**: | ||
- Load the data into R studio. | ||
- Use the `DESeq2` package (or similar) for differential expression analysis. | ||
- Filter out genes with low counts. | ||
- Normalize the data. | ||
4. **Analysis**: | ||
- Generate heatmaps, PCA plots, and other relevant plots to visualize gene expression patterns. | ||
- Save and catalog results. | ||
|
||
**Specific Conditions**: | ||
- Ensure the computer has sufficient memory and processing power for large datasets. | ||
|
||
--- | ||
|
||
### 2. **Protein Tertiary Structure Prediction and Mutation Analysis** | ||
**Materials**: | ||
- Computer with internet access. | ||
- AlphaFold2 platform access. | ||
- UCSF Chimera software. | ||
- DNA sequences for the target proteins. | ||
|
||
**Procedure**: | ||
1. **Protein Prediction**: | ||
- Navigate to the Bkunyun Platform and upload the DNA/protein sequence. | ||
- Initiate AlphaFold2 prediction and wait for results. | ||
2. **Structural Analysis**: | ||
- Download the resulting PDB files. | ||
- Open the PDB files in UCSF Chimera. | ||
- Visualize, compare, and analyze structures. | ||
3. **Mutation Analysis**: | ||
- Highlight and label mutation sites on the structures using UCSF Chimera tools. | ||
- Predict potential functional changes due to mutations. | ||
|
||
**Specific Conditions**: | ||
- Ensure a stable internet connection for online platforms. | ||
- Ensure sufficient storage space for saving PDB and other files. | ||
|
||
--- | ||
|
||
### 3. **Collagen and Elastin Purification** | ||
#### **a. Chromatography-free purification method** | ||
**Materials**: | ||
- BL21 (DE3) strain with appropriate plasmid. | ||
- PBS (pH 9.0, 0.5 M NaCl). | ||
- 10 KDa & 1 KDa ultrafiltration tubes. | ||
- HPLC system. | ||
|
||
**Procedure**: | ||
1. **Cultivation**: | ||
- Inoculate a fresh culture of BL21 in LB medium (pH 8.5) supplemented with 50 mg/L kanamycin. | ||
- Incubate at 37°C, 200 rpm until OD600 ~0.6. | ||
- Add 0.3 mM IPTG to induce protein expression and incubate overnight. | ||
2. **Protein Extraction**: | ||
- Harvest cells by centrifugation at 4,000 rpm, 15 minutes, 4°C. | ||
- Resuspend the cell pellet in 50 mL PBS. | ||
- Lyse cells using high-pressure homogenization. | ||
- Centrifuge lysed cells at 10,000 rpm, 30 minutes, 4°C to remove cell debris. | ||
3. **Ultrafiltration**: | ||
- Pass supernatant through a 10 KDa ultrafiltration tube to remove proteins >10 KDa. | ||
- Adjust pH of filtrate to 6.5 using 1 M HCl. | ||
- Incubate at 30°C overnight for potential peptide cleavage. | ||
- Pass the solution through a 1 KDa ultrafiltration tube. | ||
4. **Quality Control**: | ||
- Analyze filtrate using HPLC to assess peptide purity and concentration. | ||
|
||
**Specific Conditions**: | ||
- All steps involving cells and proteins should be done on ice or at 4°C, unless otherwise stated. | ||
- Use sterile techniques to prevent contamination. | ||
|
||
--- | ||
|
||
### 4. **ARTP-PANCE for Screening Intein and T7 RNAP Mutants In Vivo** | ||
|
||
**Materials**: | ||
- Primary M13 phage for GyrA or T7 RNAP. | ||
- S1030 strain with pJC175e plasmid. | ||
- DNA-LAMP method kit. | ||
- LB medium, appropriate antibiotics. | ||
|
||
**Procedure**: | ||
1. **Phage Addition**: | ||
- Inoculate a fresh culture of S1030 strain containing the pJC175e plasmid. | ||
- At early log phase, add the primary M13 phage. | ||
- Incubate to allow for bacterial-phage interactions. | ||
2. **ARTP Mutation**: | ||
- Centrifuge and re-suspend bacterial cells in fresh LB medium. | ||
- Expose to ARTP treatment in controlled settings for specified durations (e.g., 30s, 120W). | ||
- Dilute treated cells in fresh LB medium. | ||
3. **Phage Titer Estimation**: | ||
- Use the DNA-LAMP method to periodically measure phage titers. | ||
- When phage titer reaches 10^6 CFU/mL, proceed to the next step. | ||
4. **Phage Collection**: | ||
- Centrifuge culture and collect the supernatant containing the M13 phage. | ||
|
||
**Specific Conditions**: | ||
- Use sterile conditions throughout to prevent contamination. | ||
- The ARTP mutagenesis equipment should be calibrated to provide the right exposure intensity. | ||
- Monitor cultures for any signs of contamination or cell death. | ||
|
||
--- | ||
|
||
### 5. **CRISPR-Associated Transposon Protocol** | ||
|
||
**Materials**: | ||
- BL21 strain containing specified plasmids. | ||
- LB medium with appropriate antibiotics. | ||
- PCR equipment, reagents, and primers. | ||
- Sanger sequencing setup. | ||
|
||
**Procedure**: | ||
1. **Strain Induction**: | ||
- Inoculate BL21 strain with the necessary plasmids in LB medium with required antibiotics. | ||
- Grow until OD600 reaches 0.6. | ||
- Induce with 0.2 mM IPTG and continue incubation overnight. | ||
2. **Isolation**: | ||
- Plate culture on LB plates with antibiotics to isolate monoclonal strains. | ||
- Grow plates until colonies are visible. | ||
3. **Identification**: | ||
- Use bacterial PCR to identify strains with the desired insert fragments. | ||
- Confirm insertions through Sanger sequencing. | ||
|
||
**Specific Conditions**: | ||
- Use a controlled incubator set at 37°C for bacterial growth. | ||
- Maintain sterility throughout to avoid contamination. | ||
- Optimize PCR conditions for specific primers and target regions. | ||
|
||
--- | ||
|
||
### 6. **TADR-FADS for Screening Proline Hydroxylase Mutants** | ||
|
||
**Materials**: | ||
- BL21 strain with specific genomic modifications and plasmids. | ||
- Fluorescent microplate reader. | ||
- LB medium and appropriate antibiotics. | ||
|
||
**Procedure**: | ||
1. **Strain Transformation**: | ||
- Transform BL21 with the desired plasmid. | ||
- Grow transformed cells in LB medium with appropriate antibiotics until OD600 ~0.6. | ||
2. **Induction**: | ||
- Add 0.5 mM IPTG to the culture. | ||
- Continue overnight incubation. | ||
3. **Fluorescence Measurement**: | ||
- Measure GFP fluorescence intensity of the cultures using a fluorescent microplate reader. | ||
|
||
**Specific Conditions**: | ||
- Maintain cultures at 37°C, 200 rpm throughout. | ||
- Calibration of the microplate reader is essential for accurate fluorescence readings. | ||
|
||
--- | ||
|
||
### 7. **Microfluid Chip and Device Preparation** | ||
|
||
**Materials**: | ||
- PDMS | ||
- HFE7500 fluorinated oil. | ||
- Microscopy and imaging setup with lasers and cameras. | ||
|
||
**Procedure**: | ||
1. **Chip Fabrication**: | ||
- Create microfluidic patterns using PDMS. | ||
- Allow PDMS to cross-link and cure. | ||
- Punch the necessary ports and channels. | ||
2. **Assembly**: | ||
- Attach the PDMS structure to a glass slide. | ||
- Apply a hydrophobic surface coating. | ||
- Fill electrode holes as necessary. | ||
3. **Droplet Generation**: | ||
- Use a dropmaker chip with fluorinated oil to generate droplets. | ||
- Employ imaging equipment to monitor and manipulate droplets. | ||
|
||
**Specific Conditions**: | ||
- PDMS curing should be done under controlled temperature conditions for consistency. | ||
- Maintain a clean environment to ensure dust or contaminants do not interfere with microfluidic operations. | ||
|
||
--- | ||
|
||
### 8. **Activity Assay for Proline Hydroxylase** | ||
|
||
**Materials**: | ||
- Bacterial Protein Extraction Kit. | ||
- Hydroxyproline (HYP) content detection kit. | ||
|
||
**Procedure**: | ||
1. **Protein Extraction**: | ||
- Extract total proteins from E. coli using the extraction kit. | ||
2. **Quantification**: | ||
- Measure protein concentration using a BCA protein quantification kit. | ||
3. **Activity Assessment**: | ||
- Determine proline hydroxylation levels using the HYP content detection kit. | ||
|
||
**Specific Conditions**: | ||
- All extraction steps should be carried out at 4°C or on ice to maintain protein stability. | ||
- Ensure that all reagents, especially those in the HYP detection kit, are at the appropriate temperature and freshly prepared. | ||
- Control samples (non-hydroxylated proline samples) should be run alongside experimental samples for accurate comparison. | ||
|
||
--- | ||
|
||
### 9. **Collagen and Elastin Synthesis via CFPS Reaction** | ||
|
||
**Materials**: | ||
- 20 standard amino acids, glycine, proline, 2-oxoglutarate, etc. | ||
- Cell extract from a high yield source. | ||
- Target plasmid or DNA encoding collagen/elastin sequences. | ||
- Necessary buffers and cofactors for in vitro transcription and translation. | ||
|
||
**Procedure**: | ||
1. **Preparation**: | ||
- Thaw all reagents on ice. | ||
- Prepare a master mix containing all the components except the cell extract and DNA. | ||
2. **Reaction Setup**: | ||
- In a sterile reaction tube, mix the master mix, cell extract, and target DNA/plasmid. | ||
- Ensure thorough mixing without introducing bubbles. | ||
3. **Incubation**: | ||
- Place the reaction tube in a controlled incubator set at 37°C. | ||
- Allow the reaction to proceed for 8 hours. | ||
4. **Analysis**: | ||
- After incubation, analyze the reaction mixture for synthesized collagen/elastin using SDS-PAGE or Western Blot. | ||
|
||
**Specific Conditions**: | ||
- Ensure all components are fresh and uncontaminated. This is crucial for the efficiency of the CFPS system. | ||
- Maintain a sterile environment during the setup to prevent external protein or RNA contamination. | ||
- Optimal temperatures for the CFPS system might vary depending on the specific cell extract source. Adjust accordingly. | ||
|
||
--- | ||
|
||
### 10. **Proline Hydroxylase Mutant Screening via Microfluidic Chips** | ||
|
||
**Materials**: | ||
- Microfluidic chips prepared from PDMS. | ||
- HFE7500 fluorinated oil. | ||
- Culture of strains containing the P4Hc mutant library. | ||
- Necessary buffers and reagents for droplet generation. | ||
|
||
**Procedure**: | ||
1. **Strain Preparation**: | ||
- Grow the strains containing the P4Hc mutant library in LB medium until OD600 reaches ~0.6. | ||
- Dilute the culture for use in droplet generation. | ||
2. **Droplet Generation**: | ||
- Set up the microfluidic chip on the appropriate device. | ||
- Introduce the bacterial culture and HFE7500 fluorinated oil into the chip to generate droplets. | ||
3. **Droplet Analysis**: | ||
- Using the attached imaging system, monitor the droplets for desired phenotypes or activities. | ||
- Sort and collect droplets of interest for further analysis. | ||
|
||
**Specific Conditions**: | ||
- Ensure consistent flow rates for both the bacterial culture and the fluorinated oil to generate uniform droplets. | ||
- Calibrate the imaging system for accurate detection and analysis of droplets. | ||
- Maintain a clean setup to prevent clogging or contamination within the microfluidic channels. | ||
|
||
|